Skip to main content

Find Clinical Trials

Home
Conditions
Varicella

Clinical trial condition

Varicella

Explore clinical trials studying Varicella. Study availability and eligibility vary by location and protocol.

68 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Varicella trial results

Completed

Study to Test the Safety and Immunogenicity of VARIVAX (2007 Process) (Study V210-057) (Completed)

NCT00822237

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations: Not specified

View Trial Details

Completed

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

NCT00109343

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

NCT00092404

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Not specified

View Trial Details

Completed

Safety Study of a Refrigerator-stable Formulation of VARIVAX®

NCT00432731

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: Amboise, France

Ancenis, France

Betton, France

Châteaubriant, France

View all 25 locations

View Trial Details

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00353288

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Ancenis, France

GSK Investigational Site Boulogne, France

GSK Investigational Site Dax, France

GSK Investigational Site Draguignan, France

View all 39 locations

View Trial Details

Completed

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

NCT00352898

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Edmonton, Alberta, Canada

GSK Investigational Site Vancouver, British Columbia, Canada

GSK Investigational Site Halifax, Nova Scotia, Canada

GSK Investigational Site Enna, Sicily, Italy

View Trial Details

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00127010

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Brussels, Belgium

GSK Investigational Site Leuven, Belgium

GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

View all 48 locations

View Trial Details

Completed

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00127023

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bönnigheim, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Ehingen, Baden-Wurttemberg, Germany

View all 85 locations

View Trial Details

Completed

Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

NCT00126997

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Espoo, Finland

GSK Investigational Site Lahti, Finland

GSK Investigational Site Oulu, Finland

GSK Investigational Site Pori, Finland

View all 54 locations

View Trial Details

Completed

Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

NCT00406211

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Klagenfurt, Austria

GSK Investigational Site Neufeld/Leitha, Austria

GSK Investigational Site Salzburg, Austria

GSK Investigational Site Villach, Austria

View all 41 locations

View Trial Details